Is Going Beyond Rasch Analysis Necessary to Assess the Construct Validity of a Motor Function Scale?
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 29625093.
- Also identified by DOI 10.1016/j.apmr.2018.02.017.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To examine whether a Rasch analysis is sufficient to establish the construct validity of the Motor Function Measure (MFM) and discuss whether weighting the MFM item scores would improve the MFM construct validity. Observational cross-sectional multicenter study. Twenty-three physical medicine departments, neurology departments, or reference centers for neuromuscular diseases. Patients (N=911) aged 6 to 60 years with Charcot-Marie-Tooth disease (CMT), facioscapulohumeral dystrophy (FSHD), or myotonic dystrophy type 1 (DM1). None. Comparison of the goodness-of-fit of the confirmatory factor analysis (CFA) model vs that of a modified multidimensional Rasch model on MFM item scores in each considered disease. The CFA model showed good fit to the data and significantly better goodness of fit than the modified multidimensional Rasch model regardless of the disease (P<.001). Statistically significant differences in item standardized factor loadings were found between DM1, CMT, and FSHD in only 6 of 32 items (items 6, 27, 2, 7, 9 and 17). For multidimensional scales designed to measure patient abilities in various diseases, a Rasch analysis might not be the most convenient, whereas a CFA is able to establish the scale construct validity and provide weights to adapt the item scores to a specific disease.
Medical subject headings
- Charcot-Marie-Tooth Disease
- Disability Evaluation
- Muscular Dystrophy, Facioscapulohumeral
- Myotonic Dystrophy
- Surveys and Questionnaires